Search Results 1031-1040 of 17111 for Antagonist

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. A Study To Evaluate The Clinical Outcome Of Chimeric Antigen Receptor T-cell Therapy

    There are more clinical trials underway to test this treatment modality in different setting in these cancers and to test CAR-T in other types of cancer. As we ...

  4. AI-Guided LBBAP - Mayo Clinic

    The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and ...

  5. Translational Neuro-Oncology: Jann N. Sarkaria - Research projects

    Research in the Sarkaria Translational Neuro-Oncology Lab at Mayo Clinic focuses on ADC biology, MDM2 inhibitors, DNA damage response inhibitors and ...

  6. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with ...

  7. Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer - Mayo Clinic

    This phase II trial is studying how well giving acetylsalicylic acid together with eflornithine works in treating patients at high risk for colorectal cancer.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Oncology (Medical) - Clinical trials

    The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...

  10. Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma - Mayo Clinic

    The study was conducted to assess the safety and tolerability of (1) polyethylene glycol (PEG) PEGylated Recombinant Human Hyaluronidase (PEGPH20) in ...